menu search

Paratek pharmaceuticals to be acquired by gurnet point capital and novo holdings

Transaction Provides Paratek Shareholders with Immediate Value and Liquidity Reflects Potential Value of $3.00 per Share of Common Stock, Including Up...

June 6, 2023, 1:05 pm

Lgnd or ilmn: which is the better value stock right now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Ligand pha...

June 6, 2023, 12:45 pm

Merck just sued the biden administration: find out why

Merck & Co Inc (NYSE: MRK) is in focus this morning after the pharmaceutical giant sued the Biden admin...

June 6, 2023, 11:12 am

Here's why neurobo pharmaceuticals, inc. (nrbo) could be great choice for a bottom fisher

NeuroBo pharmaceuticals, Inc. (NRBO) appears to have found support after losing some value lately, as i...

June 6, 2023, 10:59 am

Okyo pharma begins ok-101 phase 2 dosing

OKYO Pharma said patients are being dosed in a randomise portion of a phase 2 trial for its OK-101 drug to treat dry eye disease (DED). The ophthalmo...

June 6, 2023, 10:29 am

Merck is climbing higher, with growth potential

Merck & Co is a strong investment option due to its steady growth in the pharmaceutical industry and po...

June 5, 2023, 10:48 pm

Atea pharmaceuticals to present at the jefferies healthcare conference

BOSTON, June 05, 2023 (GLOBE NEWSWIRE) — Atea pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a cl...

June 5, 2023, 8:20 pm

Atea pharmaceuticals to present at the jefferies healthcare conference

BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- Atea pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a cli...

June 5, 2023, 4:20 pm

Alnylam to webcast presentation at goldman sachs 44th annual global healthcare conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi thera...

June 5, 2023, 4:00 pm

Defender pharmaceuticals reports positive results from pivotal phase iii clinical trial of intranasal scopolamine for the prevention of nausea and vomiting induced by motion

ST. LOUIS, June 05, 2023 (GLOBE NEWSWIRE) — Defender pharmaceuticals, Inc. (the “Company” or “D...

June 5, 2023, 1:47 pm

Cardinal health's ‘outcomes' business merges with pharmacy tech firm tds

Medical products maker Cardinal Health is combining its Outcomes business with pharmacy tech firm Transaction Data Systems. The deal will give Car...

June 5, 2023, 1:04 pm

Why shares of day one pharmaceuticals are up monday

Day One has begun a rolling NDA for its candidate DAY101 as a monotherapy for relapsed or progressive pediatric low-grade glioma (pLGG). The company s...

June 5, 2023, 12:30 pm

Mink therapeutics announces virtual annual shareholders meeting

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) — MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceuti...

June 5, 2023, 11:30 am

Springworks therapeutics announces pdufa date extension for nirogacestat nda

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review; New PDUFA Date Set to November 27, 2023 STAMFORD, Conn., June 05...

June 5, 2023, 10:30 am

Lyophilized injectable market primed to surpass usd 5 billion by 2031, according to transparency market research

The market in Asia Pacific is anticipated to witness rapid growth in the near future, driven by rise in manufacturing of parenteral ...

June 5, 2023, 10:30 am

Alkeus announces $150 million series b financing, supporting rapid registration path for gildeuretinol (alk-001) in the treatment of stargardt disease

Vertex Founder and Industry Pioneer Joshua Boger, Ph.D. named as Executive Chairman of Alkeus CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Alk...

June 5, 2023, 10:00 am

Why is bellerophon therapeutics (blph) stock down 79% today?

Bellerophon Therapeutics (NASDAQ: BLPH ) stock is taking a massive beating on Monday after the pharmaceutical<...

June 5, 2023, 9:12 am

Tarsus to present at the jefferies global healthcare conference

IRVINE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Tarsus pharmaceuticals, Inc. (NASDAQ: TARS), whose mi...

June 5, 2023, 8:30 am

Algernon pharmaceuticals subsidiary completes dmt escalating dose study

Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Neu...

June 5, 2023, 8:11 am


Search within

Pages Search Results: